Paper Details

  1. Home
  2. Paper Details

Inhaled iloprost is an effective alternative therapy for persistent pulmonary hypertension in newborns.

Author: YıldırımŞükran

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study suggests that inhaled iloprost can be used as a first-line therapy for persistent pulmonary hypertension of the newborn when inhaled nitric oxide is unavailable.
Paper Details　
Original Abstract of the Article :
Persistent pulmonary hypertension of the newborn (PPHN) is one of the diseases of the neonate with severe potential morbidity and mortality. Inhaled iloprost, a stable prostacyclin analog, has been suggested as an alternative treatment for inhaled nitric oxide (iNO). However, more data on neonates' ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352650/

データ提供：米国国立医学図書館（NLM）

Inhaled Iloprost: A New Oasis in the Desert of PPHN Treatment

This retrospective study explores the use of inhaled iloprost as an alternative therapy for persistent pulmonary hypertension of the newborn (PPHN), a serious condition affecting newborns. The researchers evaluated the effectiveness of inhaled iloprost in a small cohort of newborns, demonstrating its potential as a rescue therapy when inhaled nitric oxide (iNO) is unavailable. The study highlights the need for further research to optimize the use of inhaled iloprost and establish its role as a first-line treatment option in PPHN.

A Breath of Fresh Air for Newborns

The study's findings suggest that inhaled iloprost might be a valuable alternative to iNO in treating PPHN, offering a potential solution for newborns who don't respond to traditional treatments. This research, like finding a new oasis in the desert of PPHN treatment, offers a promising avenue for improving outcomes for these vulnerable infants.

Embracing Innovation in Neonatal Care

This research encourages a forward-thinking approach to neonatal care, embracing new treatment options and exploring innovative therapies. It highlights the importance of continuous research to enhance the care of newborns and improve their chances of survival and healthy development. This journey toward better neonatal care is an ongoing quest for safer and more effective treatments, guided by a commitment to finding new oases of hope for these fragile lives.

Dr.Camel's Conclusion

This study is a camel's journey through the desert of neonatal care, highlighting the potential of inhaled iloprost as an alternative treatment for PPHN. While further research is needed, this discovery offers a glimmer of hope for newborns facing this challenging condition. The quest for better treatments for PPHN continues, driven by a dedication to improving the health and well-being of our youngest and most vulnerable patients.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-07-21
Further Info :

Pubmed ID

37469523

DOI: Digital Object Identifier

PMC10352650

Related Literature

Article Analysis
・Side Effects of iloprost
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.